Eudesmin |
Katalog-Nr.GC61941 |
Eudesmin ((-)-Eudesmin) beeintrÄchtigt die adipogene Differenzierung durch Hemmung des S6K1-Signalwegs.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 526-06-7
Sample solution is provided at 25 µL, 10mM.
Eudesmin ((-)-Eudesmin) impairs adipogenic differentiation via inhibition of S6K1 signaling pathway. Eudesmin possesses diverse therapeutic effects, including anti-tumor, anti-inflammatory, and anti-bacterial activities[1].
Treatment of mesenchymal stem cells (MSCs) with Eudesmin (20, 40, and 80µM) disturbs adipogenesis via suppression of S6K1 signaling pathway. Eudesmin treatment inhibits activation and nuclear translocation of S6K1. S6K1-mediated phosphorylation of H2B at serine 36 (H2BS36p) is reduced upon Eudesmin treatment[1].
References:
[1]. Ki Hong Nam, et al. Eudesmin Impairs Adipogenic Differentiation via Inhibition of S6K1 Signaling Pathway. Biochem Biophys Res Commun. 2018 Nov 10;505(4):1148-1153.
Average Rating: 5
(Based on Reviews and 2 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *